X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-12 | HTFL | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $24.49 | -65,153 | 221,574 | -23% | -$1,595,486 | |||||
| D | 2026-02-10 | HTFL | Farquhar John C.M. | CEO | S - Sale+OE | $27.46 | -22,562 | 591,656 | -4% | -$619,553 | |||||
2026-02-05 | HTFL | Cullivan Julie A | Dir | S - Sale | $27.32 | -8,000 | 36,413 | -18% | -$218,560 | ||||||
2026-02-04 | HTFL | Bain Capital Life Sciences Investors, LLC | 10% | S - Sale | $28.05 | -2,000,000 | 10,448,158 | -16% | -$56,100,000 | ||||||
2025-12-16 | HTFL | Lightcap Jeffrey C | Dir | P - Purchase | $26.34 | +40,000 | 6,737,556 | +1% | +$1,053,680 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |